#Coronary Heart Disease Diagnostic Imaging Devices Market | Explore Tumblr Posts and Blogs

businessmarketreports · 20 days

Text

Market Size and Growth Projections for Intravascular Ultrasound System Consoles Market

The intravascular ultrasound (IVUS) system consoles market is expected to witness significant growth in the coming years, driven by factors such as increasing prevalence of cardiovascular diseases, technological advancements, and rising healthcare spending.

Buy the Full Report for More Insights on the IVUS Consoles Market Forecast, Download a Free Sample Report

Market Size

Global: The global IVUS system consoles market was valued at [USD X billion] in 2023 and is projected to reach [USD Y billion] by 2030, growing at a CAGR of [Z%] during the forecast period.

Regional: [Mention the market size and growth rates for key regions such as North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.]

Growth Drivers

Increasing Prevalence of Cardiovascular Diseases: The rising incidence of heart diseases, such as coronary artery disease and peripheral artery disease, is driving demand for IVUS systems for accurate diagnosis and treatment planning.

Technological Advancements: Advances in IVUS technology, including high-resolution imaging, 3D visualization, and integration with other diagnostic tools, are enhancing the capabilities and adoption of IVUS systems.

Rising Healthcare Spending: The increasing healthcare spending in developed and emerging economies is fueling the growth of the medical devices market, including IVUS system consoles.

Minimally Invasive Procedures: The preference for minimally invasive procedures over open surgeries is driving demand for IVUS systems, which are used to guide these procedures.

Challenges and Opportunities

High Costs: The high cost of IVUS systems can be a barrier to adoption, particularly in resource-constrained regions.

Regulatory Hurdles: Obtaining regulatory approvals for new IVUS technologies can be time-consuming and costly.

Competition: The market is competitive, with several major players and emerging companies offering IVUS systems.

Technological Advancements: Continued advancements in IVUS technology, such as wireless connectivity and AI-powered analysis, present opportunities for growth and innovation.

Overall, the intravascular ultrasound system consoles market is poised for significant growth, driven by the increasing prevalence of cardiovascular diseases, technological advancements, and rising healthcare spending. By addressing the challenges and capitalizing on the opportunities, market players can position themselves for long-term success.

#Intravascular Ultrasound System Consoles Market

0 notes

blueweave · 22 days

Text

India Cardiovascular Devices Market size by value at USD 0.91 billion in 2023. During the forecast period between 2024 and 2030, BlueWeave expects India Cardiovascular Devices Market size to expand at a CAGR of 9.15% reaching a value of USD 1.67 billion by 2030. The Cardiovascular Devices Market in India is propelled by the escalating burden of heart failures, exacerbated by the COVID-19 pandemic. Initiatives like the National Heart Failure Biobank are playing a pivotal role in accelerating market growth by fostering research and enhancing treatment capabilities. Technological advancements, such as AI, robotics, and innovative product launches like Medtronic's Micra AV and Arctic Front, are also contributing significantly. The increasing prevalence of cardiovascular diseases among India's aging population further underscores the market's potential. As healthcare infrastructure continues to improve and awareness campaigns gain momentum, India Cardiovascular Devices Market is well-positioned to maintain a strong and steady growth trajectory.

Opportunity - Technological Advancements to Enhance Patient Care and Reduce Costs

Advancements in technology have significantly improved patient care and reduced costs in India Cardiovascular Devices Market. Innovations such as drug-eluting stents and bioresorbable alternatives enhance treatment outcomes, while cutting-edge catheterization techniques like intravascular ultrasound (IVUS) and optical coherence tomography (OCT) provide precise coronary artery imaging for better diagnosis and treatment. The rise of robotic-assisted and minimally invasive procedures reduces recovery times and complications, offering patients quicker, less painful recoveries with fewer risks. Advanced imaging technologies, including cardiac MRI and 3D echocardiography, enable accurate diagnosis and treatment planning, while implantable devices like pacemakers and defibrillators with remote monitoring capabilities efficiently manage heart rhythm disorders. Artificial intelligence (AI) and machine learning (ML) facilitate early detection and personalized treatment plans, and telemedicine enables remote consultations, broadening access, especially in underserved areas. Wearable devices and mobile apps enhance remote cardiac monitoring and rehabilitation, while 3D printing, and nanotechnology contribute to patient-specific models and advanced drug delivery systems. These technological advancements not only improve diagnostic precision and treatment efficacy but also reduce the overall cost of care by minimizing hospital stays, complications, and post-operative care needs.

Sample Request @ https://www.blueweaveconsulting.com/report/india-cardiovascular-devices-market/report-sample

#BlueWeave #Consulting #marketforecast #marketresearch #medical #healthcareindustry

0 notes

tritonmarketresearchamey · 1 month

Text

Tech Impact on Cardiovascular Ultrasound Market: Trends & Prospects

Cardiovascular diseases (CVDs) have now surpassed cancer as the leading cause of death worldwide, with nearly 17.9 million lives lost every year. They are a group of illnesses, such as coronary heart disease, rheumatic heart disease, cerebrovascular disease, and others, affecting the heart and blood vessels.

Early detection is crucial to prevent these fatalities and seek timely care. Also called cardiac ultrasound or echocardiography, cardiovascular ultrasound is an imaging system that performs a detailed clinical diagnosis of the heart and detects any underlying issues in a relatively shorter duration.

According to Triton Market Research, the global cardiovascular ultrasound market is likely to develop with a CAGR of 6.12% in the forecast period from 2022 to 2028. The rising prevalence of CVDs has enhanced the demand for echocardiography devices, which is expected to drive the global market.

Increased Disease Prevalence Worldwide – Causative Factors

In recent years, the prevalence of hypertension, high blood glucose levels, elevated blood lipid levels, obesity, etc., has increased, which are risk factors for CVDs. Obesity rates have ascended in France, affecting 17% of the population.

Also, the substantial rise in the geriatric population, which is prone to several health conditions due to aging, contributes largely to the increased disease burden. In Brazil, people aged 50-79 are the most affected. With $61.78 million, the country accounted for the largest share in Latin America’s cardiovascular ultrasound market in 2021.

Realizing the importance of timely disease diagnosis, the Government of Australia launched the Cardiovascular Health Mission in 2019, which brings together experts in this field to make transformative improvements for patients’ cardiac health. The Australian market is expected to grow the fastest in the Asia-Pacific, with a 7.89% CAGR.

Technological Advancements widen Market Scope

The cardiovascular imaging domain has evolved due to the developments in 2D, 3D/4D, and Doppler technologies in ultrasound imaging. Another technology is point-of-care ultrasound, which uses a portable system that enables assessing patients without requiring them to be physically present in a cardiology department.

Advancements in technology offer numerous benefits, such as real-time imaging, ionizing-radiation-free imaging, enhanced diagnostic accuracy, improved patient safety, etc., which have revolutionized the field of echocardiography.

At 6.87% of CAGR, Doppler imaging to show the fastest growth in the Technology segment

Doppler imaging technology can detect heart valve defects, congenital heart disease, blocked or bulging arteries, and other conditions. Doppler ultrasound systems are gaining popularity as they easily identify any problems associated with the blood flow within the heart, which are otherwise difficult to diagnose.

Lanmage’s C6 portable color Doppler ultrasound system, which offers excellent imaging quality, is equipped with powerful functions for use in cardiac, vascular, and other applications.

At 6.37% of CAGR, Fetal Echocardiography to witness rapid growth in the Type segment

Fetal echocardiography is a type of ultrasound test performed on pregnant women to examine the fetus’ heart for any structural or functional abnormalities. Its demand is rising due to increased detection rate of congenital anomalies, with congenital heart disease the most common anomaly.

LISENDO 880LE is a premium 3D/4D diagnostic ultrasound system by FUJIFILM Holdings Corporation is a preferred choice by several cardiologists for pediatric and fetal heart patients.

Companies leverage Technology with Innovative Developments

A majority of the key market players are headquartered in Europe (GE Healthcare, Siemens Healthineers, Esaote S.p.A.) and the Asia-Pacific (Dawei Medical, Leltek Inc, Zoncare), signifying the large consumer base in these regions. The industry rivalry is significantly high due to manufacturers launching new products incorporated with innovative features.

In August 2020, Netherlands-based Philips Healthcare launched the Affiniti CVx echocardiography solution. Equipped with breakthrough interventional features, it aims to support cardiology departments in delivering improved patient care.

In June 2021, Japan-based Canon Medical Corp launched the Aplio i-series/Prism Edition, with faster processing and highly detailed imaging capabilities, along with several other enhanced applications.

Artificial Intelligence to Shape Future Opportunities

The integration of artificial intelligence (AI) technology into numerous cardiac ultrasound systems has emerged as the latest trend. AI in echocardiography is vital for disease diagnosis, standard section recognition, left ventricle functionality assessment, and automatic cardiac cavity segmentation.

Besides, introducing AI in cardiovascular ultrasound imaging has eased the whole process by eliminating the need for unnecessary testing and minimizing the costs incurred.

In the coming years, artificial intelligence’s role in echocardiography would become far more pertinent in developing smart algorithms for identifying risk factors and providing a more precise diagnosis. AI incorporation thus lays the foundation for the future of the cardiovascular ultrasound market.

FAQs:

Q 1) What are the revenue estimates for the global market?

The global cardiovascular ultrasound market which was valued $1450.86 million in 2021 and is likely to reach $2194.06 million by 2028.

Q 2) Which are the key end-users of cardiovascular ultrasound systems?

Ambulatory Care Centers, Hospitals, Diagnostic Centers, and Other End-users.

#Cardiovascular Ultrasound Market #Lifescience #triton market research #market research reports

0 notes

lalsingh228-blog · 6 months

Text

Angiography Devices Market Projected to Show Strong Growth

Advance Market Analytics added research publication document on Worldwide Angiography Devices Market breaking major business segments and highlighting wider level geographies to get deep dive analysis on market data. The study is a perfect balance bridging both qualitative and quantitative information of Worldwide Angiography Devices market. The study provides valuable market size data for historical (Volume** & Value) from 2018 to 2022 which is estimated and forecasted till 2028*. Some are the key & emerging players that are part of coverage and have being profiled are GE Healthcare (United States), Siemens Healthcare (Germany), Toshiba Corporation (Japan), Medtronic Inc. (Ireland), ST. Jude Medical (United States), Abbott Vascular (United States), Boston Scientific Corporation (United States), Cordis Corporation (United States), Philips Healthcare (Netherlands), Shimadzu Corporation (Japan). Get free access to Sample Report in PDF Version along with Graphs and Figures @ https://www.advancemarketanalytics.com/sample-report/27361-global-angiography-devices-market

The Angiography devices are one type of medical imaging technique that used in visualize blood vessels in the brain, neck, heart, and kidneys. The Angiography devices used to detect the abnormalities and blood vessels blockage throughout the circulatory systems. Major driving factors for the increase of angiography devices are rise in Interventional Angiography Systems in Minimally Invasive Surgeries and government funding activities. This factor is expected to boost the global market. The major companies are adding more proven technologies systematically and strategically in Asia-Pacific countries as these countries are focused on better health facilities. Keep yourself up-to-date with latest market trends and changing dynamics due to COVID Impact and Economic Slowdown globally. Maintain a competitive edge by sizing up with available business opportunity in Angiography Devices Market various segments and emerging territory. Influencing Market Trend

Upsurge demand of innovative technology such as MRA & CT and digital flat panel detectors devices

Market Drivers

Upsurge Investment in Healthcare Sector.

Increase in Prevalence of Cardio-Vascular Diseases.

Opportunities:

Rise in Aging Population Leads to Boost the Angiography Devices Market.

Technological Developments in Healthcare Sectors Lead to Grow the Angiography Devices Market.

Challenges:

It can only be Applicable in Active Bleeding.

Have Any Questions Regarding Global Angiography Devices Market Report, Ask Our Experts@ https://www.advancemarketanalytics.com/enquiry-before-buy/27361-global-angiography-devices-market Analysis by Type (X-Ray Angiography Devices, CT Angiography Devices, MR Angiography Devices), Application (Diagnostic, Therapeutic), Indication (Known Suspected CAD, Valvular Heart Disease, Congenital Heart Disease, Congestive Heart Failure, Others), Procedure (Coronary Angiography, Micro Angiography, Non Coronary Angiography), End-Users (Hospitals, Diagnostic Centers, Academics & Research laboratories)

Competitive landscape highlighting important parameters that players are gaining along with the Market Development/evolution

• % Market Share, Segment Revenue, Swot Analysis for each profiled company [GE Healthcare (United States), Siemens Healthcare (Germany), Toshiba Corporation (Japan), Medtronic Inc. (Ireland), ST. Jude Medical (United States), Abbott Vascular (United States), Boston Scientific Corporation (United States), Cordis Corporation (United States), Philips Healthcare (Netherlands), Shimadzu Corporation (Japan)]

• Business overview and Product/Service classification

• Product/Service Matrix [Players by Product/Service comparative analysis]

• Recent Developments (Technology advancement, Product Launch or Expansion plan, Manufacturing and R&D etc)

• Consumption, Capacity & Production by Players The regional analysis of Global Angiography Devices Market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world. Whereas, owing to rising no. of research activities in countries such as China, India, and Japan, Asia Pacific region is also expected to exhibit higher growth rate the forecast period 2023-2028. Table of Content Chapter One: Industry Overview Chapter Two: Major Segmentation (Classification, Application and etc.) Analysis Chapter Three: Production Market Analysis Chapter Four: Sales Market Analysis Chapter Five: Consumption Market Analysis Chapter Six: Production, Sales and Consumption Market Comparison Analysis Chapter Seven: Major Manufacturers Production and Sales Market Comparison Analysis Chapter Eight: Competition Analysis by Players Chapter Nine: Marketing Channel Analysis Chapter Ten: New Project Investment Feasibility Analysis Chapter Eleven: Manufacturing Cost Analysis Chapter Twelve: Industrial Chain, Sourcing Strategy and Downstream Buyers Read Executive Summary and Detailed Index of full Research Study @ https://www.advancemarketanalytics.com/reports/27361-global-angiography-devices-market Highlights of the Report • The future prospects of the global Angiography Devices market during the forecast period 2023-2028 are given in the report. • The major developmental strategies integrated by the leading players to sustain a competitive market position in the market are included in the report. • The emerging technologies that are driving the growth of the market are highlighted in the report. • The market value of the segments that are leading the market and the sub-segments are mentioned in the report. • The report studies the leading manufacturers and other players entering the global Angiography Devices market. Thanks for reading this article; you can also get individual chapter wise section or region wise report version like North America, Middle East, Africa, Europe or LATAM, Southeast Asia. Contact US : Craig Francis (PR & Marketing Manager) AMA Research & Media LLP Unit No. 429, Parsonage Road Edison, NJ New Jersey USA – 08837 Phone: +1 201 565 3262, +44 161 818 8166 [email protected]

#Global Angiography Devices Market #Angiography Devices Market Demand #Angiography Devices Market Trends #Angiography Devices Market Analysis #Angiography Devices Market Growth #Angiography Devices Market Share #Angiography Devices Market Forecast #Angiography Devices Market Challenges

0 notes

mrfr-blogs · 7 months

Text

Unveiling the Research Behind Cardiac Catheterization Market Services

Market Overview –

The Cardiac Catheterization Market encompasses medical procedures and equipment used to diagnose and treat heart conditions through minimally invasive techniques. Cardiac catheterization involves inserting a catheter into a blood vessel and guiding it to the heart to perform diagnostic tests, visualize blood flow, and deliver therapeutic interventions such as angioplasty and stent placement.

One significant driver of the Cardiac Catheterization Market's growth is the increasing prevalence of cardiovascular diseases globally. Conditions such as coronary artery disease, heart failure, and valvular heart disease contribute to the growing demand for cardiac catheterization procedures as clinicians seek to diagnose and manage these conditions promptly.

Advancements in catheterization techniques, imaging technologies, and interventional cardiology devices have also fueled market growth by improving procedural outcomes, reducing complications, and expanding the scope of minimally invasive cardiac interventions. Additionally, the shift towards outpatient procedures and same-day discharge protocols has increased the efficiency and accessibility of cardiac catheterization services, driving further demand.

Moreover, the aging population and the rising adoption of sedentary lifestyles contribute to the increasing burden of cardiovascular diseases, further driving the demand for cardiac catheterization procedures. As healthcare systems prioritize preventive cardiology, early diagnosis, and timely intervention, the Cardiac Catheterization Market is expected to continue growing, offering opportunities for innovation and collaboration among medical device manufacturers, healthcare providers, and researchers.

The Cardiac Catheterization Market, often referred to as the cardiology catheter market, is experiencing significant growth attributed to advancements in minimally invasive procedures for diagnosing and treating heart conditions. With a rise in cardiovascular diseases globally, the demand for these catheters is increasing, propelling market expansion.

The Cardiac Catheterization Market was valued at USD 0.35 billion in 2022. The Cardiac Catheterization market is expected to increase from USD 0.3731 billion in 2023 to USD 26.4 billion by 2032, with a compound yearly growth rate (CAGR) of 7.4% over the forecast period (2023-2032).

Market Segmentation –

The market is segmented into five Key dynamics for an easy grasp.

By Procedures: Balloon Septostomy, Coronary Angioplasty, Catheter Ablation, Bipolar Pacing, Left Heart Catheterization, and Right Heart Catheterization among others.

By Types: Fractional Flow Reserve, Coronary Angiogram, Intravascular Ultrasound, and Optical Coherence Tomography among others.

By Applications: Heart Attack, Abnormal Stress Test, Coronary Vasospasm, and Cardiac Arrhythmia, among others.

By End-Users: Hospitals and Clinics among others.

By Regions: Comprises Geographical regions - North America, Europe, APAC and Rest of the World.

Regional Analysis –

The regional analysis of the cardiac catheterization market reflects disparities in healthcare infrastructure, prevalence of cardiovascular diseases, and adoption of minimally invasive procedures. North America leads the market, driven by advanced healthcare facilities, high prevalence of cardiovascular conditions, and early adoption of innovative technologies. Europe follows suit, with robust investments in healthcare infrastructure and increasing demand for minimally invasive cardiac procedures. In the Asia-Pacific region, improving access to healthcare services, rising disposable incomes, and growing awareness about cardiovascular health contribute to market growth. Developing regions in Latin America and Africa are also witnessing gradual market expansion as healthcare infrastructure improves and awareness about cardiovascular diseases increases.

Key Players –

Cardiac catheterization market Key companies include St. Jude Medical (US), Medtronic Inc. (US), Becton, Dickinson, and Company (US), Terumo Medical Corporation (Japan), Teleflex Incorporated (US), Edwards Life Sciences Corporation (US), Abbott (US), Boston Scientific Corporation (US), Rochester Medical Corporation (US), Johnson & Johnson Private Limited (US), Dispocard GmbH (Germany), Maquet Medical India Private Limited (India), and Coloplast (Denmark).

Related Reports –

US Melanoma

Middle East and Africa HIV Diagnosis & Treatment

Gastroparesis Treatment

Dental Infection Treatment

For more information visit at MarketResearchFuture

#Cardiac Catheterization Market #Cardiac Catheterization Market Size #Cardiac Catheterization Market Share #Cardiac Catheterization Market Trends #Cardiac Catheterization Market Growth

0 notes

desaletushki · 1 year

Text

Cardiovascular Ultrasound Market Size, Share & Trends Analysis Report, 2030

The global cardiovascular ultrasound market size is expected to reach USD 4.01 billion by 2030 and expand at a CAGR of 4.96% during the forecast period, based on a new report by Grand View Research, Inc. The primary factor driving cardiovascular ultrasounds is that new imaging technologies have improved the accuracy and resolution of images obtained from echocardiography machines. This makes it easier for clinicians to identify and diagnose diseases. Additionally, it provides non-invasive diagnostic options, which are often preferred over invasive procedures.

Request Sample Report: https://www.grandviewresearch.com/industry-analysis/cardiovascular-ultrasound-system-market/request/rs15?utm_source=medium&utm_medium=referral&utm_campaign=tushar-d_ict_3-july-23&utm_term=cardiovascular-ultrasound-system-market&utm_content=request_sample

Benefits associated with cardiovascular ultrasound over conventional methods include quick recovery, reduced span of hospitalization, and fewer post-operative complications. These benefits along with the rising geriatric population are expected to propel the demand for cardiovascular ultrasound diagnosis over the forecast period.

North America captured the largest market share in 2022. A favorable reimbursement framework and the presence of a large number of industry players are some of the major factors which can be attributed to regional growth. The rising geriatric population coupled with sophisticated healthcare infrastructure is expected to further fuel market growth in the region. Furthermore, increasing health awareness is driving demand.

COVID-19 has had a significant impact on CVUS. One of the most noticeable effects of the pandemic has been the delays in elective procedures, including those related to CVUS. As a result, which reduces the demand for imaging equipment and services. However, the pandemic has also led to an increase in telemedicine adoption, which includes the use of remote monitoring devices and virtual consultations. This led to increased use of portable devices and an expansion of the market.

Cardiovascular Ultrasound Market Report Highlights

The cardiovascular ultrasound in the healthcare market size was estimated at USD 2.69 billion in 2022 and is expected to reach USD 4.01 billion in 2023

The global cardiovascular ultrasound in the healthcare market is expected to expand at a compound annual growth rate of 4.96% from 2022 to 2030 to reach USD 4.01 billion by 2030

In 2022, North America dominated the market in terms of the revenue share of 29.1%. The market's growth in the region is increasing due to an increase in cardiovascular diseases across the region

Cardiovascular Ultrasound Market Segmentation

Grand View Research has segmented the Cardiovascular ultrasounds based on type, technology, display, end-use:

Cardiovascular Ultrasound Type Outlook (Revenue, USD Million, 2018 - 2030)

Transthoracic Echocardiography

Transesophageal Echocardiography

Fetal Echocardiography

Others

Cardiovascular Ultrasound Technology Outlook (Revenue, USD Million, 2018 - 2030)

3D/4D

Doppler

Cardiovascular Ultrasound Display Outlook (Revenue, USD Million, 2018 - 2030)

B/W

Color

Cardiovascular Ultrasound End-use Outlook (Revenue, USD Million, 2018 - 2030)

Hospital

Diagnostic Centers

Ambulatory Care Centers

Other

Regional Insights

North America dominated the global market and accounted for a revenue share of 29.1% in 2022. This is attributed to cardiovascular disease which is one of the leading causes of death in the region, with conditions such as coronary artery disease, hypertension, and heart failure affecting a significant proportion of the population. This has led to a greater demand for diagnostic tools, such as cardiovascular ultrasound, to assess and monitor cardiovascular health.

The Asia Pacific region is expected to grow at the fastest CAGR of 5.37% owning to advancements in technology that have made cardiovascular ultrasound machines more accurate, efficient, and accessible. Additionally, economic growth in the region has led to an expansion of the middle class and increased healthcare spending. This has led to greater demand for advanced medical technologies, including cardiovascular ultrasound.

List of Key Players in the Cardiovascular Ultrasound Market

GE Healthcare

Koninklijke Philips

Siemens Healthineers AG

Hitachi Medical Corp.

Samsung Medison Co. Ltd.

Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (Mindray)

Chison Wuxi Xiangsheng Medical Technology Co., Ltd.

Fujifilm Sonosite, Inc.

Buy Full Report: https://www.grandviewresearch.com/checkout/select-license/cardiovascular-ultrasound-system-market?utm_source=medium&utm_medium=referral&utm_campaign=tushar-d_ict_3-july-23&utm_term=cardiovascular-ultrasound-system-market&utm_content=request_sample

0 notes

techninja · 1 year

Text

Cardiovascular Monitoring and Diagnostic Devices Market Poised for Steady Growth in 2023

Introduction:

The global cardiovascular monitoring and diagnostic devices market is set to witness substantial growth in 2023, driven by advancements in technology, rising prevalence of cardiovascular diseases, and increasing awareness about early detection and prevention. These devices play a pivotal role in the diagnosis, monitoring, and management of cardiovascular conditions, enabling healthcare professionals to provide timely interventions and improve patient outcomes. With a focus on precision, portability, and user-friendliness, manufacturers are introducing innovative solutions that are revolutionizing cardiovascular care.

Growing Prevalence of Cardiovascular Diseases:

Cardiovascular diseases, including heart attacks, strokes, and coronary artery diseases, remain the leading cause of mortality worldwide. The increasing prevalence of risk factors such as obesity, sedentary lifestyles, unhealthy diets, and tobacco use continues to contribute to the burden of cardiovascular diseases. As a result, there is a pressing need for effective monitoring and diagnostic devices to detect and manage these conditions.

Technological Advancements Driving Market Growth:

Technological advancements have significantly improved the capabilities and efficiency of cardiovascular monitoring and diagnostic devices. Wearable devices, such as smartwatches and fitness bands, equipped with heart rate monitors and electrocardiogram (ECG) sensors, are gaining popularity among consumers. These devices allow individuals to track their heart health in real-time and provide valuable data to healthcare professionals.

Moreover, advancements in non-invasive imaging techniques, such as cardiac magnetic resonance imaging (MRI) and computed tomography (CT) scans, have improved the accuracy and efficiency of cardiovascular diagnosis. These imaging modalities provide detailed anatomical information, allowing healthcare providers to make informed decisions regarding treatment plans.

Increasing Emphasis on Remote Monitoring:

The COVID-19 pandemic has underscored the importance of remote monitoring in healthcare. With restrictions on in-person visits, remote monitoring devices have become indispensable tools in managing cardiovascular conditions. Remote monitoring enables healthcare professionals to track patients' vital signs, such as heart rate, blood pressure, and oxygen saturation, from a distance. This technology ensures timely intervention and reduces the risk of complications, especially for high-risk patients.

Market Outlook for 2023:

The cardiovascular monitoring and diagnostic devices market is expected to experience steady growth in 2023. The market will be driven by the increasing adoption of wearable devices and the growing demand for non-invasive diagnostic tools. Additionally, the aging population and the rising prevalence of chronic diseases will contribute to market growth.

Emerging economies, particularly in Asia-Pacific and Latin America, present significant opportunities for market players. The expanding healthcare infrastructure, improving reimbursement policies, and increasing disposable income in these regions are expected to fuel market growth. Furthermore, collaborations between device manufacturers and healthcare providers are likely to drive innovation and the development of cost-effective solutions tailored to regional needs.

Conclusion:

The cardiovascular monitoring and diagnostic devices market is poised for steady growth in 2023, driven by technological advancements, the rising prevalence of cardiovascular diseases, and the emphasis on remote monitoring. These devices have the potential to improve patient outcomes by enabling early detection, accurate diagnosis, and timely interventions. As the industry continues to evolve, manufacturers and healthcare providers must collaborate to develop innovative solutions that enhance cardiovascular care and improve patient well-being.

0 notes

mrudula01 · 1 year

Text

Tech Impact on Cardiovascular Ultrasound Market: Trends & Prospect

Increased Disease Prevalence Worldwide – Causative Factors

Technological Advancements widen Market Scope

At 6.87% of CAGR, Doppler imaging to show the fastest growth in the Technology segment

Lanmage’s C6 portable color Doppler ultrasound system, which offers excellent imaging quality, is equipped with powerful functions for use in cardiac, vascular, and other applications.

At 6.37% of CAGR, Fetal Echocardiography to witness rapid growth in the Type segment

LISENDO 880LE is a premium 3D/4D diagnostic ultrasound system by FUJIFILM Holdings Corporation is a preferred choice by several cardiologists for pediatric and fetal heart patients.

Companies leverage Technology with Innovative Developments

Artificial Intelligence to Shape Future Opportunities

Besides, introducing AI in cardiovascular ultrasound imaging has eased the whole process by eliminating the need for unnecessary testing and minimizing the costs incurred.

FAQs:

Q 1) What are the revenue estimates for the global market?

The global cardiovascular ultrasound market which was valued $1450.86 million in 2021 and is likely to reach $2194.06 million by 2028.

Q 2) Which are the key end-users of cardiovascular ultrasound systems?

Ambulatory Care Centers, Hospitals, Diagnostic Centers, and Other End-users.

0 notes

rohittriton · 2 years

Text

Tech Impact on Cardiovascular Ultrasound Market: Trends & Prospects

Increased Disease Prevalence Worldwide – Causative Factors

Technological Advancements widen Market Scope

At 6.87% of CAGR, Doppler imaging to show the fastest growth in the Technology segment

At 6.37% of CAGR, Fetal Echocardiography to witness rapid growth in the Type segment

LISENDO 880LE is a premium 3D/4D diagnostic ultrasound system by FUJIFILM Holdings Corporation is a preferred choice by several cardiologists for pediatric and fetal heart patients.

Companies leverage Technology with Innovative Developments

Artificial Intelligence to Shape Future Opportunities

Besides, introducing AI in cardiovascular ultrasound imaging has eased the whole process by eliminating the need for unnecessary testing and minimizing the costs incurred.

FAQs:

Q 1) What are the revenue estimates for the global market?

The global cardiovascular ultrasound market which was valued $1450.86 million in 2021 and is likely to reach $2194.06 million by 2028.

Q 2) Which are the key end-users of cardiovascular ultrasound systems?

Ambulatory Care Centers, Hospitals, Diagnostic Centers, and Other End-users.

0 notes

impossibledeanmakerwombat · 2 years

Text

Angiography Devices Market to Latest Research, Industry Analysis, Driver, Trends, Business Overview, Key Value, Demand And Forecast 2023 to 2032

In 2022, the global angiography devices market is expected to be worth $12,116.7 million. The expanding scope of application and technological innovation are expected to be the primary growth drivers in the market. Overall angiography device sales are expected to grow at a 6.2% CAGR between 2022 and 2032, totaling around US$ 22,112 million by the end of 2032.

Angiography is an imaging procedure which provides visualization of blood vessel to detect narrow, blocked, enlarged arteries or veins in the body. Local or general anesthesia has been given to the patient during angiography procedure. This procedure uses various imaging technologies such as, Magnetic Resonance Imaging, Computed Tomography, X-ray and others. The superior quality of angiography imaging over conventional techniques is increasing the adoption of angiography devices especially for heart related disorders.

The MRI and CT angiography devices would be the most prominent products in this market owing to its efficacy, minimal side effects and short duration in terms of outcome. Commercialization of high end imaging technologies and increasing affordability of patients has increases the scope of hybrid angiography devices, in developed region. The demand for angiography devices in developing region would get reduced owing to its relatively saturated market situation. This market would be further driven by replacement of old devices.

Request Free Report Sample @ http://www.futuremarketinsights.com/reports/sample/rep-gb-1186

Angiography Devices Market: Overview

By device, the angiography device market was dominated by more advanced technologies such as MRI and CT, owing to their high efficiency over conventional technologies. Recently launched, Real-time 3D echocardiography by Siemens Healthcare is one of the key development in angiography devices market, which is used to diagnose various heart and coronary conditions. By procedure, coronary angiography and pulmonary angiography are the dominating procedure, owing to its high prevalence. By end-users, hospitals and surgical centers hold promising share, followed by diagnostic centers. This is due to premium pricing of angiography devices, which is unaffordable for the medium scale diagnostic centers. By disease indication, Coronary Artery Disease (CAD) is the leading segment due to its high incidence and absence of alternative diagnostic technique.

Angiography Devices Market: Drivers and Restraints

Increasing CVD incidences, growing number of geriatric population, dysfunctional lifestyle, growing demand for sophistication diagnostic procedures are driving the growth of angiography devices market, globally. Also, the rising awareness for cardiovascular disease diagnosis and treatment, favorable government regulation to commercialize angiography devices are the additional factors fueling the growth of angiography devices market. However, the high cost angiography devices, lack of reimbursement, and unaffordability across emerging economies are some of the factors impeding the market growth. However, the companies operating in this market are actively focusing on the commercialization of low cost system to grab the highest market share in emerging economies.

Enquiry/Query @ https://www.futuremarketinsights.com/ask-question/rep-gb-1186

Angiography Devices Market: Segmentation

The global angiography devices market is segmented based on, device, product type, application, procedures, end use and indication.

Based on devices, the global angiography devices market is segmented into the following:

Magnetic Resonance Angiography (MRA)

Computed Tomography Angiography (CTA)

Conventional Angiography

Digital Subtraction Angiography (DSA)

Catheter angiography

Coronary angiography

Others

Based on procedure, the global angiography devices market is segmented into the following:

Coronary Angiography

Pulmonary Angiography

Cerebral Angiography

Extremity Angiography

Renal Angiography

Based on end users, the global angiography devices market is segmented into the following:

Hospitals and Surgical Centers

Diagnostics Centers

Academic and Research Institutes

Based on indication, the global angiography devices market is segmented into the following:

Coronary Artery Disease (CAD)

Congenital Heart Disease

Congestive Heart Failure

Kidney Disorders

Others

Request For TOC @ http://www.futuremarketinsights.com/toc/rep-gb-1186

Angiography Devices Market: Region-wise Outlook

North America was the lading region for angiography devices in terms of revenue in 2015, followed by Europe. Increasing incidence of coronary disorder owing to dysfunction lifestyle is the prime factor driving the growth of angiography device market in these region. However, the similar kind of trend is now shifting towards emerging economies which is expected to create notable growth opportunity for the angiography device during the forecast period.

Angiography Devices Market: Key Players

Leading players operating in angiography devices includes, Shimadzu Corporation, Royal Philips Electronics, Siemens Healthcare, GE Healthcare, Toshiba Medical System Corporation, Shimadzu Corporation, St. Jude Medical, Inc., Toshiba Medical Systems Corporation, Cordis Corporation, Medtronic, Inc., and Abbott Vascular (Abbott Laboratories). Companies operating in this market are seeking for novel product to gain core competencies in the market. These companies are also conducting collaborative studies with the clinical research institutes to sustain their market position.

Full Report @https://www.futuremarketinsights.com/reports/angiography-devices-market

0 notes

marketinsightshare · 2 years

Text

Vascular Closure Devices Market - Forecast(2022 - 2027)

Vascular Closure Devices Market size is estimated to reach $1.4 billion by 2027, growing at a CAGR of 6.9% during the forecast period 2022-2027. Vascular closure devices are medical devices utilized to accomplish hemostasis of the tiny hole in the artery subsequent to a cardiovascular procedure of endovascular surgery needing a catheterization. Angio-Seal is a medical device designated for application in closing and minimizing time to hemostasis at the femoral arterial puncture site in patients who have endured diagnostic angiography procedures or interventional procedures (minimal artery diameter of 4mm). The VasoSeal hemostatic devices (VasoSeal Elite and VasoSeal ES; Datascope, Montvale, NJ) are collagen-based vascular closure devices that use a purified collagen plug to emphasize hemostasis. To redistribute these devices, a dilator and a sheath are collectively progressed over a guidewire to the surface of the femoral artery. Vascular surgical techniques involve a count of complicated and controversial operations carried out by the most distinguished vascular surgeons from across the globe. The surging acceptance of Vascular Closure Devices including hemostatic devices for diagnostic and therapeutic interferences that assist the progress of endovascular image-guided interferences to discover coronary heart disease is set to drive the Vascular Closure Devices Market. The capability of vascular closure devices to overpower complexities like extended bed rest and patient discomfort brought about by manual compression is set to propel the growth of the Vascular Closure Devices Market during the forecast period 2022-2027. This represents the Vascular Closure Devices Industry Outlook.

Report Coverage

The report: “Vascular Closure Devices Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Vascular Closure Devices Market.

By Product Type: Active Approximators (Clip-Based Devices, Suture-Based Devices, Plug-Based Devices), Passive Approximators (Hemostatic Pads & Patches, Compression Devices). By Mode Of Access: Femoral Access, Redial Access. By End User: Hospitals, Ambulatory Surgical Centers, Others. By Geography: North America (U.S, Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia & New Zealand, and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia, Rest of South America), and Rest Of The World (Middle East, Africa).

Key Takeaways

Geographically, North America Vascular Closure Devices Market accounted for the highest revenue share in 2021 and it is poised to dominate the market over the period 2022-2027 owing to the increasing predominance of cardiovascular diseases involving the application of hemostatic devices in cardiovascular devices in the North American region.

Vascular Closure Devices Market growth is being driven by the surging recognition of femoral artery cardiac catheterization and the soaring success rate of vascular closure devices for enhanced patient comfort and decreasing hemostasis time. However, in the developing regions of South America and Asia-Pacific, determinants like the soaring price of products, complexities linked with vascular closure devices,s and lesser acceptance rates of new technologies are some of the major factors hampering the growth of the Vascular Closure Devices Market.

Vascular Closure Devices Market Detailed Analysis of the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Vascular Closure Devices Market report.

Vascular Closure Devices Market: Market Share (%) by Region, 2021

For More Details on This Report - Request for Sample

Vascular Closure Devices Market Segment Analysis – By Product Type:

The Vascular Closure Devices Market based on product type can be further segmented into Active Approximators and Passive Approximators. The Active Approximators Segment held the largest market share in 2021. This growth is owing to the surging application of active approximators attributed to the diminished time to ambulation. Clip-Based Devices, Suture-Based Devices, and Plug-Based Devices are categories under Active Approximators and Angio-Seal includes two hemostatic techniques namely, active approximation and thrombosis. The soaring efficiency rate in comparison with manual compression is further propelling the growth of the Active Approximators segment.

Furthermore, the Passive Approximators segment is estimated to grow with the fastest CAGR of 7.5% during the forecast period 2022-2027 owing to the surging application of compression assisted devices, which accomplish hemostasis without inserting a retained suture, clip, or plug, and passive approximators like Angio-Seal.

Vascular Closure Devices Market Segment Analysis – By End User:

The Vascular Closure Devices Market based on end-user can be further segmented into Hospitals, Ambulatory Surgical Centers, and Others. The Hospitals segment held the largest market share in 2021. This growth is owing to the surging application of Vascular Closure Devices as a secure and cost-effective technique to accomplish accelerated hemostasis and early ambulation subsequent to angiographic techniques. Angio-Seal® vascular closure device-induced acute arterial closure has been successfully treated percutaneously with the SilverHawk® plaque excision system. The effortless accessibility of well-established infrastructure and availability of skilled physicians in hospitals are further propelling the growth of this segment.

Furthermore, the Ambulatory Surgical Centers segment is estimated to grow with the fastest CAGR of 7.8% during the forecast period 2022-2027 owing to the extensive application of Vascular Closure Devices like Angio-Seal in ambulatory care.

Vascular Closure Devices Market Segment Analysis – By Geography:

The Vascular Closure Devices Market based on geography can be further segmented into North America, Europe, Asia-Pacific, South America, and Rest of the World. North America (Vascular Closure Devices Market) held the largest share with 35% of the overall market in 2021. The growth of this region is owing to the surging assortment of opportunities drawing novel investors in the North American region. Angio-Seal is a closure device utilized for halting the bleeding subsequent to angiography techniques like cardiac catheterization. The proliferating demand for sophisticated medical devices is further propelling the growth of the Vascular Closure Devices Market in the North American region.

Furthermore, the Asia-Pacific region is estimated to be the region with the fastest CAGR rate over the forecast period 2022-2027. This growth is owing to factors like surging development in developing economies like India and China in the Asia-Pacific region. The existence of unfamiliar areas and unfulfilled patient requirements drawing the attention of key players and the surging application of closure devices like Angio-Seal is further fueling the progress of the Vascular Closure Devices Market in the Asia-Pacific region.

Vascular Closure Devices Market - Drivers

Surging Investigations Involving Vascular Closure Devices Are Projected To Drive The Growth Of the Vascular Closure Devices Market:

Vascular closure devices (VCDs) are planned to accomplish accelerated hemostasis at the time of percutaneous coronary and peripheral vascular techniques. Investigations show that VCDs enhance time to hemostasis (TTH) and time to ambulation (TTA) when compared to standard manual compression. The investigation assessed AbsorbaSeal™ (CyndRx, LLC, Brentwood, Tennessee), a clear, three-step, VCD with bio-absorbable constituents. The investigation concluded that the AbsorbaSeal™ is secure and simple to utilize for vascular closure subsequent to interventional vascular techniques with favorable results inclusive of a short TTH, minimum procedural blood loss, low postoperative pain scores, and no perioperative complexities or adverse impacts. Histologic assessment discloses accelerated device absorption and little scar formation both short- and long-term. A direct investigation of complement activation backs that AbsorbaSeal™ induces a minimal inflammatory response that is considerably less than Angio-Seal. Application of AbsorbaSeal™ 5.6.7F vascular closure device in a good laboratory practice chronic investigation assessing safety and efficiency in a healthy porcine model have demonstrated the following results. In the deployment of 24 AbsorbaSeal™ 5.6.7F VCDs, there were nil device-associated complexities or mortalities. All deployments led to accelerated arteriotomy seal (100% deployment success), with a mean time to hemostasis (cessation of arterial flow) of 21.5 s (median: 6.5 s) across a mean activated clotting time (ACT) of 356 s. Twenty of the 24 implant sites (83%) accomplished complete hemostasis within 20 s. These kinds of surging investigations involving Vascular Closure Devices are therefore fuelling the growth of the Vascular Closure Devices Market during the forecast period 2022-2027.

Novel Product Launches Involving Vascular Closure Devices Are Expected To Boost The Demand For Vascular Closure Devices:

Devices like Angio-Seal are currently in application. Angio-Seal is on the market for >20 years, with approved favorable device deployment and efficiency in plentiful clinical randomized trials:

99.7% deployment success

97.8% hemostasis by device

In November 2018, Cordis, a Cardinal Health firm, introduced its Mynx Control vascular closure device onto the U.S. market. A press release reported that the Mynx Control vascular control device combines active extravascular sealing and resorbability characteristics with a next-generation delivery system to augment predictability, security, and ease of application in sealing 5–7Fr femoral arterial access sites. The press release further indicates that the vascular closure device characterizes a next-generation deployment system that is planned for predictable deployment and ease of application. It will be accessible in 5Fr and 6/7Fr sizes. The novel product launches involving Vascular Closure Devices are therefore driving the growth of the Vascular Closure Devices Market during the forecast period 2022-2027.

Vascular Closure Devices Market – Challenges

Soaring Cost Of Vascular Closure Devices Are Hampering The Market Growth:

Presently, it is supposed that only 20-25% of all catheter-based procedures carried out globally use a vascular closure device (VCD) for access site hemostasis. The boost in interventional techniques utilizing radial access, the soaring cost of vascular closure devices, and the hazards related to vascular closure devices are the principal limitations to the growth of the market. The requirement for greatly skilled professionals is challenging the growth of the market. A massive count of catheter-based techniques is carried out without vascular closure devices owing to a dearth of operator knowledgeableness, the hazard of complexities, and cost. Most vascular closure devices are authorized for arteriotomies between 5 and 8F, with 1 device authorized for up to 21F. Principal complexities are inclusive infection and limb ischemia. These issues are thus hampering the growth of the Vascular Closure Devices Market.

Vascular Closure Devices Industry Outlook:

Product launches, mergers and acquisitions, financing in R&D, and novel market initiatives are key strategies adopted by players in the Vascular Closure Devices Market. Key companies in this market are:

Abbott

Terumo Corporation

Cardinal Health Inc.,

Teleflex

Merit Medical System

Cardiva Medical, Inc.

Biotronik GMBH & CO.KG

Scion BioMedical

Medtronic

Cook Medical

Recent Developments

In July 2021, Terumo Corporation declared the introduction of the Dexcom G6 continuous glucose monitoring (CGM) system in Japan. U.S.-based Dexcom, Inc., makes the product, and Terumo holds the exclusive distribution agreement in Japan since their partnership in 2018. A CGM system is a medical device that backs diabetes regulation.

In December 2020, Cook Medical declared the introduction of a novel Customer Portal to offer an improved digital and self-serve customer experience. This user-friendly Customer Portal provides numerous characteristics, certain vary relying on region, which provide customers information and interactive operations. The Customer Portal has been introduced in the U.S. and EMEA regions earlier this year and is presently being launched to their clients in the Asia-Pacific region.

In April 2020, Abbott has introduced its third test for coronavirus (COVID-19) and is transporting tests to hospitals across the U.S. The test is a serology test – also termed an antibody test – which could be a crucial next step in combating this virus. Abbott's test assists to discover the IgG antibody to SARS-CoV-2.

#Vascular Closure Devices Market share #Vascular Closure Devices Market size #Vascular Closure Devices Marketforecast

0 notes

adityarana1687-blog · 2 years

Text

Coronary Heart Disease Diagnostic Imaging Devices Market Predicted To Surpass $2.96 Billion By 2030

The global coronary heart disease diagnostic imaging devices market is expected to reach USD 2.96 billion by 2030, registering a CAGR of 6.9% from 2022 to 2030, according to a new report by Grand View Research, Inc. Increase in coronary diseases and deaths associated with it calls for better and early diagnosis of the condition. Precise scan interpretation and technologically advanced equipment are the factors influencing the market growth. Various imaging modalities are useful in identifying unique aspects of coronary screening. For instance, intravascular ultrasound, X-ray angiography, and computed tomography angiography (CTCA) provide a direct evaluation and quantification of alterations in the coronary arteries. However, non-invasive techniques like single-photon computed tomography (SPECT) and positron emission tomography (PET) provide indirect information on CHD by estimating the myocardial perfusion and metabolism abnormalities that are consequent of coronary artery disease.

Technological advancement in this field had led to the development of sharp camera units consisting of gamma systems, that use semiconductor detectors of cadmium zinc telluride (CZT). This led to faster acquisition of images, reduced capture time, high image quality, and lower radiation dose (1mSv for a single injection), as compared to conventional myocardial perfusion imaging by SPECT. Further, improvements around Computed Tomography, to develop non-invasive techniques have also shown great future growth in this segment. However, economic barriers, subject literacy, and lack of medical staff hold back the implementation of such advanced techniques in real practice.

The coronary heart disease diagnostic imaging devices market saw a sharp decline in 2020, due to the outbreak of the COVID-19 pandemic. Fear of virus spread, the shift in focus on diagnosing and treating COVID-19 affected patients, reduced admission rates at hospitals for other diseases, and reduced medical staff, led to the reduction in the diagnosis of CVD. Economic setback observed by end-users also influenced the adoption of advanced techniques to effectively diagnoses coronary alterations. Further, the shutting down of manufacturing units, due to national lockdowns, halt in logistics, and reduction in salesforce also impacted the market negatively. However, diabetic and hypertensive patients witnessed a severe risk of CVD ultimately leading to death. Thus, the pandemic significantly impacted the market in 2020, which is likely to stabilize and grow exponentially by 2022.

Request a free sample copy or view report summary: Coronary Heart Disease Diagnostic Imaging Devices Market Report

Coronary Heart Disease Imaging Devices Market Report Highlights

Nuclear medicine dominated the modality segment due to the ease of image interpretation and accuracy in detection.

Computed tomography held the highest CAGR of 7.6% due to its advantages of early detection of even the most intricate alterations which otherwise is impossible to det4ect in the traditional SPECT technology.

Asia Pacific is anticipated to be growing at the fastest CAGR over the forecast period owing to the increase in R&D activities and numerous resellers.

Coronary Heart Disease Imaging Devices Market Segmentation

Grand View Research has segmented the global coronary heart disease imaging devices market based on modality and region:

Modality Outlook (Revenue, USD Million,2018 - 2030)

Computed Tomography

X rays

Ultrasound

Magnetic Resonance Imaging

Nuclear Medicine

Regional Outlook (Revenue, USD Million, 2018 - 2030)

North America

Europe

Asia Pacific

Latin America

Middle East & Africa

U.S.

Canada

U.K.

Germany

France

Italy

Spain

Norway

Denmark

Netherlands

Poland

Austria

Switzerland

Japan

China

India

South Korea

Brazil

Mexico

Argentina

South Africa

Saudi Arabia

UAE

List of Key Players in Coronary Heart Disease Imaging Devices Market

Fujifilm

Siemens

Toshiba

Hitachi

Koninklijke Phillips

Canon Medical Systems Corporation

Analogic Corp

#Coronary Heart Disease Diagnostic Imaging Devices Market

0 notes

techsciresearch · 3 years

Text

CT Scanners Market to grow at a 5.67% CAGR through 2026 | TechSci Research

Growing prevalence of chronic diseases to drive the growth of Global CT Scanners Market in the upcoming five years, 2022-2026.

According to TechSci Research report, “Global CT Scanners Market By Slice (8-slice, 16-slice, 32-slice, 64-slice, 128-slice & above), By Modality (Fixed v/s Mobile), By Device Architecture (O-arm v/s C-arm), By Application (Cardiology, Oncology, Neurology, Others), By End Users (Hospitals, Diagnostic Centers, Others), By Region, Competition Forecast & Opportunities, 2026”, the global CT scanners market was valued at around USD7.25 billion in 2020 and is anticipated to grow at an impressive rate of 5.67% in the forecast period 2022-2026. This can be attributed to the rising awareness and demand for early diagnosis of chronic diseases which can help in better management and treatment of diseases. Moreover, the doctors prefer lesser invasive diagnostic procedures, like body scans to identify the ailment, which thereby leads to increased demand for CT scanners among end users. The global CT scanners market is bound to grow exponentially in the forecast years owing to these reasons. Due to the onset of COVID-19 and imposition of complete lockdown to mitigate the coronavirus, there has been shutdown of many manufacturing units and disruption in the supply chain, which resulted in interrupted production and lesser supply of CT scanners all around the globe. However, CT scanners market was not drastically affected by the pandemic. This is due to drastic increase in demand for effective management. and treatment, as they were shown to be effective in diagnosis of COVID-19.

Browse over 163 market data Figures spread through 110 Pages and an in-depth TOC on " Global CT Scanners Market"

https://www.techsciresearch.com/report/ct-scanners-market/7295.html

Global CT scanners market is segmented by slice, modality, device architecture, application, end users, and regional distribution. Based on slice, the market is segmented into 8-slice, 16-slice, 32-slice, 64-slice, 128-slice & above. Among these 128-slice and above is expected to grow at fastest rate with CAGR of 6.96% in the forecast period. The reason for this could be its wide application in different diseases. The 128- slice is advanced technology and has broad range of application. Additionally, 128-slice CT scan technology provides extraordinary image quality and faster scanning speed than the lower slice predecessors. Moreover, higher slices mean less space between the slices and therefore a reduction in chance of missing something necessary for diagnosis. Siemens Healthineers AG has introduced SOMATOM Definition AS CT scanner, which comes with adaptive dose shield that enables the system to adjust radiation exposure levels to serve patients of different needs and ages.

On the basis of application, the CT scanners market is segmented into cardiology, oncology, neurology, and others. Cardiology segment is expected to dominate the market with 41.24% market share by 2026. This can be ascribed to the rising number of cardiovascular diseases and requirement of early diagnosis of diseases. As per World Heart Federation, cardiovascular diseases are leading cause of death across the globe. Moreover, 31% deaths across the globe are due to cardiovascular diseases, which can attributed to the change in lifestyle and increasing rate of obesity among people.

Some of the major competitors in the market are Siemens Healthineers AG, GE Healthcare, Koninklijke Philips N.V., Canon Medical Systems Corporation, Medtronic, Plc., Shimadzu Corporation, Accuray Incorporated, Hitachi Medical Corporation, Samsung Medison Co., Ltd., Carestream Health, Inc., Planmed Oy, Koning Corporation, Pointnix Co., Ltd., AB-CT - Advanced Breast-CT GmbH, Brainlab AG, among others. The companies are focusing on extensive research and development activities to stay competitive in the market. Other competitive strategies include formation of alliances and partnerships. In 2017, GE Healthcare introduced an advanced dedicated cardiovascular CT scan system, namely, CardioGraphe which creates 3D images of coronaries, valves, chambers and myocardium in one heartbeat. In January 2020, Allengers Medical Systems Limited launched the first made in India 32-slice CT scanner in collaboration with Canon Medical Systems.

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7295

Customers can also request for 10% free customization on this report.

“CT scanners are now commercialized and that is anticipated to boost the growth of market for O-arm CT scanners in upcoming years. Moreover, wide range applications of the O-arm CT scanners, makes them a promising sector for investments. Increasing cases of different chronic disease and increasing geriatric population is expected to drive the market. Additionally, patient inclination toward early diagnosis, which helps in better management of disease is expected to fuel the market growth during forecast period. Regionally, Asia Pacific is expected to be the highest growing market through 2026. Many new investors may invest in due to high demand in region,” said Mr. Karan Chechi, Research Director with TechSci Research, a research based Global management consulting firm.

“Global CT Scanners Market By Slice (8-slice, 16-slice, 32-slice, 64-slice, 128-slice & above), By Modality (Fixed v/s Mobile), By Device Architecture (O-arm v/s C-arm), By Application (Cardiology, Oncology, Neurology, Others), By End Users (Hospitals, Diagnostic Centers, Others), By Region, Competition Forecast & Opportunities, 2026”, has evaluated the future growth potential of Global CT Scanners Market and provides statistics & information on market size, structure and future market growth. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment decisions. Besides, the report also identifies and analyzes the emerging trends along with essential drivers, challenges, and opportunities in Global CT Scanners Market.

Browse Related Reports:

Global Diagnostic Imaging Market By Product Type ( Architecture (Open/Closed), By Field Strength (High and Very-High Field MRI Systems), By Systems (Ultrasound Systems, Nuclear Imaging Systems, X-Ray Imaging Systems, CT Scanner, MRI System, Mammography System, Fluoroscopy), By Portability (Stationary, Portability), By Application (OB/Gyn, Orthopaedic, Musculosekeletal, Neuro &Spine, General Imaging, Cardio &Thoracic, Breast health, Others), By End Users (Hospitals, Diagnostic Imaging Centers, Others), By Region, Forecast & Opportunities, 2016-2026F

https://www.techsciresearch.com/report/diagnostic-imaging-market/4634.html

United States Diagnostic Imaging Market By Type (X-Ray Imaging Solutions, Ultrasound Systems, MRI Systems, CT Scanners, Nuclear Imaging Solutions, Mammography, Others), By Mobility (Portable v/s Standalone), By Application (Cardiology, Oncology, Neurology, Orthopedics, Gastroenterology, Gynecology, Others), By End Users (Hospitals & Clinics, Diagnostic Centers, Ambulatory Care Centers, Others), By Region, Forecast & Opportunities, 2025

https://www.techsciresearch.com/report/united-states-diagnostic-imaging-market/4948.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Global CT Scanners Market #CT Scanners Market #CT Scanners Market Size #CT Scanners Market Forecast #Healthcare

1 note · View note

techscimarketresearch · 3 years

Text

CT Scanners Market to grow at a 5.67% CAGR through 2026 | TechSci Research

Growing prevalence of chronic diseases to drive the growth of Global CT Scanners Market in the upcoming five years, 2022-2026.

Browse over 163 market data Figures spread through 110 Pages and an in-depth TOC on " Global CT Scanners Market"

https://www.techsciresearch.com/report/ct-scanners-market/7295.html

Download Sample Report @ https://www.techsciresearch.com/sample-report.aspx?cid=7295

Customers can also request for 10% free customization on this report.

Browse Related Reports:

https://www.techsciresearch.com/report/diagnostic-imaging-market/4634.html

https://www.techsciresearch.com/report/united-states-diagnostic-imaging-market/4948.html

Contact

Mr. Ken Mathews

708 Third Avenue,

Manhattan, NY,

New York – 10017

Tel: +1-646-360-1656

Email: [email protected]

Website: https://www.techsciresearch.com/

For More Market Research Blogs Visit: https://techsciblog.com/

#TechSci #Market Research Reports #Global CT Scanners Market #CT Scanners Market #CT Scanners Market Size #CT Scanners Market Forecast #Healthcare

1 note · View note

fmihealthcareresearch · 2 years

Text

Balloon Catheter Market Size touched a valuation of US$ 5.11 billion in 2021 and is likely to reach US$ 55.99 billion in 2031

Balloon Catheter Market Size is expected to reach US$ 5.11 Bn, registering a CAGR of 4.0% over the forecast period (2021-2031). Balloon catheter market is expected to contribute nearly 5.9% of the global catheter market topping US$ 55.99 Bn by the end of 2031.

Demand for balloon catheters is expected to increase owing to rising prevalence of coronary artery diseases across the globe. Balloon catheters are used to treat various types of cardiovascular issues, includinhg cardiac catheterization as a diagnostic imaging procedure to assess a patient's heart function.

H1-2022 outlook period in comparison to H1-2022 projected period showed a negative growth in terms of Basis Point Share by 20 BPS. However, In H1-2022, the market growth rate of balloon catheters is expected to fall by 19 basis point share (BPS), as per FMI analysis

The market decline observed through the reduction in the BPS values is addressed by the high cost of balloon catheters, limitations to patent rights for established products, and lack of reimbursement plans for several catheter associated procedures.

The key developments in the market include the launch of the newest-generation drug-coated balloon catheter 'Prevail™' for the treatment of coronary artery disease, by Medtronic. The market is highly influenced by the rising prevalence of chronic diseases and lifestyle associated diseases.

2016-2020 Balloon Catheter Demand Outlook Compared to 2021-2031 Forecast

According to Future Market Insights (FMI), the sales of balloon catheter grew at a CAGR of nearly 2.9% between 2016 and 2020. With changing lifestyle habits, smoking, pollution, and rising stress levels are major factors boosting the prevalence of cardiovascular diseases worldwide.

In 2020, Boston Scientific Corporation launched the brand new imaging catheter for peripheral imaging known as Opticross 35. This product enhances the depth and variety of the company's already vast product portfolio with adding a greater IVUS depth and a 360 degree clear image quality.

The market is consolidated and is dominated by players such as Boston Scientific Inc., Medtronic, Terumo Corporation, B. Braun Melsungen AG, MicroPort Scientific Corporation, and Jotech GmbH, opines FMI.

Future Market Insights expects the global market of balloon catheter to grow at a CAGR of 4.0% by the end of 2031. Growth in the market is also attributable to the extensive research and development initiatives which is assisting in actualizing different innovative technologies.

How will Advancements in Interventional Cardiology Fuel Demand for Balloon Catheter?

Interventional cardiology has played a crucial role in coronary artery disease treatment. Patients suffering from coronary artery disease opt for cardio interventional treatment due to its less complex nature compared to other treatment solutions.

Cardiac interventions are minimally invasive and have less complications compared to other type of procedures. Hence, due to the ease in convenience and comfort, patients are opting for these procedures. This is expected to boost the balloon catheter market.

What are the Key Opportunities for Market Players?

Shifting of device manufacturing plants to low-cost economies such as India, China, and ASEAN countries due to expanding patient pool is creating growth opportunities for manufacturers. Rising prevalence of CAD and increase in angioplasty patients is increasing the demand for balloon catheters.

For instance, in February 2021, Terumo Corporation acquired all assets of Health Outcomes Science Inc. This step will ensure improvement in patient outcome with the help of personalized predictive analytics and clinical decisions. Predictive analytic might also be beneficial in improving detection statistics for coronary artery diseases and other complications associated with it.

Country-wise Insights

Will the U.S. Remain Lucrative Pocket in Balloon Catheter Market?

In 2021, the U.S. is estimated to account for over 89.0% of the North America market. Demand for balloon catheters will be on the rise due to presence of leading manufacturers, increased patient awareness, availability of advanced health care facilities and infrastructure, and technological advancements.

To improve the existing products in order to get better results, some of the leading players in the U.S. are focusing on novel product launches. They are also investing extensively in research and development activities to develop advanced balloon catheters devices.

Why is the U.K. Considered Most Remunerative Ballon Catheter Market in Europe?

The U.K. is expected to account for nearly 20.2% of the market in Europe by 2031. Growth in the region is underpiined by growing aging population, efficient health care infrastructure, and an emphasis on the development of innovative technology as well as enhanced patient diagnosis.

Furthermore, the country reports a high number of hospital admissions due to heart attacks. This eventually is expected to lead to an increase in angioplasty procedures, further boosting the market for balloon catheters.

What Are The Factors Supporting Balloon Catheters Sales in China?

The China ballon catheter market is expected to grow at around 4.6% CAGR during the forecast period. High prevalence of coronary artery disease, coupled with increasing demand for cardiac interventions is facilitating the growth in the country.

To capitalize on increasing demand, balloon catheter manufacturers are eyeing the China market for untapped potential to boost their sales.

How will Sales of Balloon Catheters Surge in India?

Recording the highest CAGR of 5.8%, India is set to be the hub for balloon catheters market, finds FMI. India is expected to dominate the South Asia balloon catheter market, accounting for 57.5% of market share in 2021.

Additonally, presence of skilled interventional cardiologists and other personnel are boosting the medical tourism in the country, creating growth opportunities for balloon catheter market players in India.

Category-wise Insights

Why are Normal Balloon Catheters Gaining Traction?

By product, the normal balloon catheters segment contributs for highest market share of 43.9% in 2021. Growth in the segment is attributable to growing preference for basic and low stenting procedures.

Hence, demand for normal balloon catheters is increasing and the trend is likely to continue over the forecast period.

Will Growing Prevalence of Coronary Artery Disease Boost Balloon Catheters Market?

By indication, coronary artery disease is anticipated to account for nearly 71.5% market share in terms of value. High prevalence of coronary artery diseases across the globe is increasing the demand for balloon catheters.

As per FMI, the polyurethane segment is expected to hold second-largest share, accounting for nearly 34% of market share in 2021.

Key Companies Profiled:

Boston Scientific Inc.

Medtronic

Terumo Corporation

Braun Melsungen AG

MicroPort Scientific Corporation

Jotech GmbH

QX Medical LLC

Competitive Landscape

Prominent players operating in balloon catheter market are focusing on expansion of their product portfolio by introducing novel product launches. They are also opting for inorganic expansion strategies such as mergers and acquisitions.

For instance,

Medtronic PLC, in July 2021 introduced a novel type of catheter into their large arsenal, a balloon catheter which can elute drugs at the target site. This product introduced into the European market for CAD by the name of Prevail Drug Coated Balloon, improves the pushability of the catheter as well as its deliverability into the complex anatomies. The drug on the balloon gets absorbed into the target arterial tissue and tries to decrease the chances of in-stent restenosis.

Information Source: https://www.futuremarketinsights.com/reports/balloon-catheter-market

#Balloon Catheter Market #Balloon Catheter Market Size #Balloon Catheter Market Share #Balloon Catheter Market Growth

0 notes

tritonmarketresearch · 2 years

Text

Tech Impact on Cardiovascular Ultrasound Market: Trends & Prospects

Increased Disease Prevalence Worldwide – Causative Factors

Technological Advancements widen Market Scope

Lanmage’s C6 portable color Doppler ultrasound system, which offers excellent imaging quality, is equipped with powerful functions for use in cardiac, vascular, and other applications.

LISENDO 880LE is a premium 3D/4D diagnostic ultrasound system by FUJIFILM Holdings Corporation is a preferred choice by several cardiologists for pediatric and fetal heart patients.

Companies leverage Technology with Innovative Developments

Artificial Intelligence to Shape Future Opportunities

Besides, introducing AI in cardiovascular ultrasound imaging has eased the whole process by eliminating the need for unnecessary testing and minimizing the costs incurred.

#Cardiovascular Ultrasound Market #healthcare #medical devices #Medical Devices and Consumables #consumables #market research report #market research reports #triton market research

0 notes